2021
DOI: 10.3389/fimmu.2021.749325
|View full text |Cite
|
Sign up to set email alerts
|

Interferon-λ Improves the Efficacy of Intranasally or Rectally Administered Influenza Subunit Vaccines by a Thymic Stromal Lymphopoietin-Dependent Mechanism

Abstract: Previous work showed that interferon-λ (IFN-λ) can trigger the synthesis of thymic stromal lymphopoietin (TSLP) by specialized epithelial cells in the upper airways of mice, thereby improving the performance of intranasally administered influenza vaccines. Here we demonstrate that protein-only influenza vaccines containing either IFN-λ or TSLP boosted antigen-specific IgG1 and IgA responses and enhanced the resistance of mice to influenza virus challenge, irrespective of whether the vaccines were applied via t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
9
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
1

Relationship

2
4

Authors

Journals

citations
Cited by 6 publications
(9 citation statements)
references
References 38 publications
0
9
0
Order By: Relevance
“…Treatment of mice with IFN-λ augmented weight recovery and reduced T. gondii brain colonization without affecting T. gondii cysts sizes (Figure 4A-D), confirming our results that IFN-λ acts early during T. gondii infection by limiting parasite dissemination. IFN-λ serves as an mucosal adjuvant, promoting humoral responses in a thymic stromal lymphopoietin (TSLP)-dependent manner 2,29 . Interestingly, we found higher levels of secreted IgG1 after 30 days of T. gondii infection in the IFN-λ-treated group compared to non-treated mice ( Suppl.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Treatment of mice with IFN-λ augmented weight recovery and reduced T. gondii brain colonization without affecting T. gondii cysts sizes (Figure 4A-D), confirming our results that IFN-λ acts early during T. gondii infection by limiting parasite dissemination. IFN-λ serves as an mucosal adjuvant, promoting humoral responses in a thymic stromal lymphopoietin (TSLP)-dependent manner 2,29 . Interestingly, we found higher levels of secreted IgG1 after 30 days of T. gondii infection in the IFN-λ-treated group compared to non-treated mice ( Suppl.…”
Section: Discussionmentioning
confidence: 99%
“…IFN-λ is therefore believed to act locally as the first line of defense against invading pathogens on mucosal surfaces possibly without activating the detrimental immune responses mediated by IFN type I 28,1,13 . IFN-λ has also been described to enhance adaptive immune responses at these sites 2,29 .…”
Section: Introductionmentioning
confidence: 99%
“…TSLP can drive allergic Th2 responses with the production of cytokines IL-4, IL-5, IL-13, and TNF-a via regulating OX40 ligand expression on DCs. Our work recently highlights the adjuvant activity of TSLP in inducing antiviral protective immunity (15,16). Moreover, TSLP has been implicated in chronic inflammation, autoimmune diseases, and cancer (11,(17)(18)(19)(20)(21).…”
Section: Introductionmentioning
confidence: 92%
“…The same results can be observed when TSLP is given together with another IAV vaccine haemagglutinin (HA), a commercial influenza vaccine containing particle-derived hemagglutinin. In TSLPR deficient ( Tslpr -/- ) mice, intranasal immunization with the IAV vaccine fails to boost neither antigen-specific IgG1 nor nucleoprotein-specific CD8 + T cells compared with WT mice ( 33 , 35 ). Taken together, these data verify the non-redundant role of TSLP in mucosal adaptive immunity, whether administrated alone or combined with vaccination.…”
Section: Tslp In Mucosal Adaptive Immunitymentioning
confidence: 99%
“…With the further deepening of research, numerous reports regarding the responsibility of IFN-III in stimulating adaptive antiviral immunity continue to emerge ( 2 , 16 , 30 32 ). Particularly, the revealed mechanism of thymic stromal lymphopoietin (TSLP) unveils the mysterious role of IFN-III in orchestrating adaptive immune response ( 33 35 ). The assistance of TSLP in IFN-III-mediated immunoregulatory faculties triggers our interest in further research.…”
Section: Introductionmentioning
confidence: 99%